NXTCL — NextCell Pharma AB Cashflow Statement
0.000.00%
Last trade - 00:00
- SEK89.66m
- SEK68.86m
- SEK10.11m
C2019 August 31st | 2020 August 31st | 2021 August 31st | 2022 August 31st | 2023 August 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | SAS | SAS | SAS | SAS | SAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -18 | -17.7 | -24.8 | -35 | -41 |
Depreciation | |||||
Non-Cash Items | 0.003 | -0.007 | 0.264 | 0.122 | -0.003 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -1.03 | -1.65 | -1.46 | 1.13 | -3.27 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -18.7 | -19 | -25.6 | -33.3 | -43.8 |
Capital Expenditures | -0.402 | -0.87 | -5.84 | -9.35 | -4.1 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 0 | 0.28 | 0 | — | — |
Sale of Fixed Assets | |||||
Cash from Investing Activities | -0.402 | -0.59 | -5.84 | -9.35 | -4.1 |
Financing Cash Flow Items | 0.179 | 0.441 | -16.1 | 0.608 | 0.836 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Cash from Financing Activities | 36.1 | 21.4 | 149 | 0.608 | 0.836 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 17 | 1.83 | 117 | -42.1 | -47.1 |